Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares jumped 22.12% in after-hours trading to $1.27 on Tuesday, following the company’s fiscal year 2025 business update and the commercial launch of its flagship oncology therapy.Check out the current price of CTXR stock here. LYMPHIR Launch Marks First... Read more
Benzinga - Dec 24
Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior administration officials said,... Read more
Dallas News - Dec 19
The eighth-largest pharmaceuticals company in the world, Swiss-based Novartis, is planning a $280 million manufacturing plant in Denton. Read more
Dallas News - Dec 15
Private jets owned by six of the largest U.S. drugmakers have touched down in Washington-area airports 127 times this year, while millions of Americans are struggling to afford prescription drugs, highlighting the greed of the pharmaceutical industry and the need for bipartisan reform. Read more
The Hill - Dec 13
ERJ Open Research article reports that Glasmacinal, a novel macrolide, was well tolerated and reduced neutrophilic inflammation in COPD patients. Read more
Globenewswire_fr - Dec 08
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 6.85% on an annualized basis producing an average annual return of 18.9%. Currently, Vertex Pharmaceuticals has a market capitalization of $116.23 billion. Buying $100 In VRTX: If ...Full story available on... Read more
Benzinga - Dec 05
The United States and the United Kingdom have agreed on a zero-tariffs deal for medications manufactured in Britain. The NHS will pay more for drugs. Read more
Upi - Dec 01
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 14.96% on an annualized basis producing an average annual return of 23.64%. Currently, Regeneron Pharmaceuticals has a market capitalization of $79.69 billion. Buying $1000 In REGN: If ...Full story avai... Read more
Benzinga - Nov 24
Shuttle Pharmaceuticals Holdings Inc. (NASDAQ:SHPH) rose 27.87% in after-hours trading on Thursday, reaching $2.34.Check out the current price of SHPH stock here.The stock of the biotech closed Thursday's regular session down 7.58% at $1.83, according to Benzinga Pro data.S-1 Registration Stateme... Read more
Benzinga - Nov 21
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.What Is the Expected CAGR for the Disintegration Tester Market Through 2025?The disintegration testing equipment sector has experienced Read more
Openpr.com - Nov 19
